Personalized Medicine – News and Features

Researchers from Singapore, South Korea, Japan, Thailand and India have assembled the world's first Asian Immune Diversity Atlas – a multi-national survey of human blood at single-cell resolution.

Three-dimensional models allow researchers to better represent complex tissues and cell-cell interactions. This article explores the cell models currently used by researchers to understand disease and aid drug discovery.

A large study of ADHD medications reveals small increases in blood pressure and heart rate. Despite concerns, these changes are generally not clinically significant. The findings suggest that cardiovascular monitoring is still important.

A recent study found that placenta-derived IL1α under hypoxic conditions, can greatly increase growth of human stem cell-derived liver organoids. This method offers a promising route to improve organoid models and regenerative medicine.

Explore how proteomics, AI and microsampling are advancing biomarker discovery. Learn how these innovations are shaping the future of precision medicine.

New findings on how the gut microbiome influences drug metabolism and effectiveness could open the door to personalized medicines and better treatment outcomes.

Certain antibiotic-resistant infections could be treated with precision medicine in the future, thanks to a new resource mapping plasmids − the ultimate vehicle of rapid bacterial evolution.

A research team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumors in chicken eggs and analyzing their proteins.

Researchers have developed new AI models that can vastly improve accuracy and discovery within protein science. Potentially, the models will assist the medical sciences in overcoming present challenges within personalized medicine and drug discovery.

A novel PET imaging method successfully quantifies COX-2 enzyme levels in the human brain. This technique opens the door for earlier detection, monitoring of disease progression, and evaluating anti-inflammatory treatments for brain disorders.